Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$71.58 - $87.29 $5,368 - $6,546
75 Added 0.82%
9,234 $676,000
Q4 2023

Feb 09, 2024

SELL
$73.27 - $83.09 $61,839 - $70,127
-844 Reduced 8.44%
9,159 $741,000
Q3 2023

Nov 06, 2023

SELL
$73.94 - $80.67 $20,407 - $22,264
-276 Reduced 2.69%
10,003 $749,000
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $4,788 - $5,462
63 Added 0.62%
10,279 $792,000
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $154,001 - $175,455
-1,992 Reduced 16.32%
10,216 $847,000
Q4 2022

Feb 06, 2023

BUY
$62.32 - $89.47 $99,525 - $142,883
1,597 Added 15.05%
12,208 $1.05 Million
Q3 2022

Nov 01, 2022

SELL
$59.54 - $68.01 $2,083 - $2,380
-35 Reduced 0.33%
10,611 $655,000
Q2 2022

Aug 01, 2022

BUY
$57.72 - $65.01 $103,491 - $116,562
1,793 Added 20.25%
10,646 $658,000
Q1 2022

May 05, 2022

BUY
$57.92 - $72.58 $299,678 - $375,528
5,174 Added 140.64%
8,853 $526,000
Q1 2019

May 14, 2019

BUY
$62.53 - $70.05 $230,047 - $257,713
3,679 New
3,679 $239,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Gyl Financial Synergies, LLC Portfolio

Follow Gyl Financial Synergies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.